The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Latest News

Olpasiran Reduces Oxidized Phospholipids on ApoB in OCEAN(a)-DOSE Trial | Image Credit: Mount Sinai
Olpasiran Reduces Oxidized Phospholipids on ApoB in OCEAN(a)-DOSE Trial

February 12th 2025

Olpasiran sustained reductions in oxidized phospholipids on apoB in patients with ASCVD and elevated Lp(a) levels in the Phase 2 dose-ranging trial.

Cardiovascular Hospitalizations Burden the US More than Denmark | Image Credit: Beth Israel Deaconess Medical Center
Cardiovascular Hospitalizations Burden the US More than Denmark

February 10th 2025

FDA Accepts Lerodalcibep BLA for LDL-C Reduction in High-Risk Patients | Image Credit: US Food and Drug Administration
FDA Accepts Lerodalcibep BLA for LDL-C Reduction in High-Risk Patients

February 10th 2025

Secondary Prevention Medications for CVD Underutilized in Global Analysis | Image Credit: McMaster University
Secondary Prevention Medications for CVD Underutilized in Global Analysis

February 9th 2025

Age May Modify Cardioprotective Effects of SGLT2 Inhibitors, GLP-1 RAs | Image Credit: Danie Franco/Unsplash
Age May Modify Cardioprotective Effects of SGLT2 Inhibitors, GLP-1 RAs

February 6th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.